Tutorials
Ionis Pharmaceuticals Inc logo

Ionis Pharmaceuticals Inc

$ 46.11 +1.85 (+4.18%) 04:00 PM EST
P/E:
At Loss
P/B:
9.21
Market Cap:
$ 6.54B
Enterprise V:
$ 5.45B
Volume:
1.06M
Avg Vol (2M):
958.11K
Also Trade In:
Volume:
1.06M
Market Cap $:
6.54B
PE Ratio:
At Loss
Avg Vol (2-Month):
958.11K
Enterprise Value $:
5.45B
PB Ratio:
9.21
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Ionis Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
2855 Gazelle Court, Carlsbad, CA, USA, 92010
Description
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy. Ionis subsequently brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019).
Name Current Vs Industry Vs History
Cash-To-Debt 1.68
Equity-to-Asset 0.28
Debt-to-Equity 1.72
Debt-to-EBITDA 64.98
Interest Coverage 5.83
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.7
Distress
Grey
Safe
Beneish M-Score -2.4
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 69.24
9-Day RSI 69.73
14-Day RSI 67.52
6-1 Month Momentum % 9.2
12-1 Month Momentum % -3.66

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.86
Quick Ratio 9.76
Cash Ratio 8.98
Days Inventory 693.22
Days Payable 355.52

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.8

Financials (Next Earnings Date:2022-11-03 Est.)

IONS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:IONS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 840.768
EPS (TTM) ($) -0.2
Beta 0.6
Volatility % 32.86
14-Day RSI 67.52
14-Day ATR ($) 1.86403
20-Day SMA ($) 39.7205
12-1 Month Momentum % -3.66
52-Week Range ($) 25.04 - 46.15
Shares Outstanding (Mil) 141.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ionis Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More